Trials / Active Not Recruiting
Active Not RecruitingNCT04888702
Holter of Movement in Patients with SMA Undergoing Treatment.
Holter of Movement in Patients with Type 2 or 3 Spinal Muscular Atrophy When Initiating Treatment with Spinraza ° or Risdiplam. Acti-SMA Study.
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Liege · Academic / Other
- Sex
- All
- Age
- 6 Years
- Healthy volunteers
- Not accepted
Summary
Acti-SMA is a multi-centric academic study. It aims to monitor the progress of patients with spinal muscular atrophy under treatment with Spinraza° or risdiplam. First, we want to quantify improvement of both ambulant and non-ambulant patients under treatment. A secondary objective would also be to identify suitable accelerometric measurements that are sensitive to change but also well correlated to other clinical scores.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Actimyo | Actimyo° is an innovative device intended to be used in a home-based environment. It is composed of two watch-like sensors, each containing a magneto-inertial sensors that record the linear acceleration, the angular velocity, the magnetic field of the movement in all directions.The two watches can be worn as wristwatch or placed near the ankle. |
Timeline
- Start date
- 2018-08-08
- Primary completion
- 2025-01-30
- Completion
- 2025-05-30
- First posted
- 2021-05-17
- Last updated
- 2025-02-12
Locations
3 sites across 2 countries: Belgium, Romania
Source: ClinicalTrials.gov record NCT04888702. Inclusion in this directory is not an endorsement.